Funded Tech Companies

Clasp Therapeutics

Wondering who provided funding to Clasp Therapeutics? Vivo Capital, Catalio Capital Management and American Cancer Society joined the equity holders in this healthcare services company.

Company Overview

Contact Information

Company Background Information

Overview

At Clasp Therapeutics, we are expanding the reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type. This approach enables a highly selective paradigm where every patient has the opportunity to respond to treatment.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/20/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Ross

        

Chief Scientific Officer

Andrea van Elsas

        

Chief Technical Officer

James Bingham

        

VP - Bus. Development

Julie DeSander

        

VP - Bus. Development

Shannon Devens

        

VP - Human Resources

Caren Block

        

Company Investors

• Vivo Capital
• Catalio Capital Management
• American Cancer Society
• Third Rock Ventures
• Pictet Alternative Advisors
• Blackbird Ventures
• Novo Holdings

Browse more funded tech companies:

Clasp | Class Companion

Share this article

About Our VC Funding Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary